CN113693973A - 一种双层精华水及其制备方法 - Google Patents
一种双层精华水及其制备方法 Download PDFInfo
- Publication number
- CN113693973A CN113693973A CN202111174469.3A CN202111174469A CN113693973A CN 113693973 A CN113693973 A CN 113693973A CN 202111174469 A CN202111174469 A CN 202111174469A CN 113693973 A CN113693973 A CN 113693973A
- Authority
- CN
- China
- Prior art keywords
- double
- water
- skin
- solution
- essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000003756 stirring Methods 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000000661 sodium alginate Substances 0.000 claims description 6
- 235000010413 sodium alginate Nutrition 0.000 claims description 6
- 229940005550 sodium alginate Drugs 0.000 claims description 6
- 239000000679 carrageenan Substances 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 229940113118 carrageenan Drugs 0.000 claims description 5
- 208000018999 crinkle Diseases 0.000 claims description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- 229940083957 1,2-butanediol Drugs 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 4
- 241000221095 Simmondsia Species 0.000 claims description 4
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 239000008169 grapeseed oil Substances 0.000 claims description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 4
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 4
- 229940094944 saccharide isomerate Drugs 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 239000011148 porous material Substances 0.000 abstract description 7
- 238000007670 refining Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 43
- 239000000686 essence Substances 0.000 description 36
- 239000010410 layer Substances 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 7
- 230000008859 change Effects 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/03—Liquid compositions with two or more distinct layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及日用化学品技术领域,目的是提供一种双层精华水,本发明除了补水功效外,还能调节混合性肌肤水油不平衡的状态、细致毛孔,提高肌肤整体的透彻感、滋润感。对比目前市场上销售的精华水,不仅效果提升明显,而且具有轻盈清爽的质地外观。
Description
技术领域
本发明涉及日用化学品技术领域,更具体地说,它涉及一种双层精华水及其制备方法。
背景技术
目前市场上的保湿水多为单层的保湿水,护理皮肤过于简单。对于易过敏性皮肤(典型的城市肌肤),特别是在秋冬季节、湿度低的北方区域,单层精华水由于不含有油脂,也不能添加较多的油性成分,其肤感比较干涩,使用后不能维持长效的滋润保湿效果。
市场上也有双层的精华液产品,但由于配方选择的不合适,出现油相与水相在短时间内分层的现象,既不方便使用,也影响使用效果;另外,分层后的精华液多为浑浊状态,外观上让消费者难以接受。
发明内容
针对现有技术存在的不足,本发明的目的在于提供一种油滴能均匀存在于水层间,外观清澈透明的双层精华水,具有保湿控油、细致毛孔、提高肌肤透彻感、滋润感的功效。
本发明的另一目的在于提供上述双层精华水的制备方法。
为实现上述目的,本发明采用如下技术方案:
一种双层精华水,按质量百分比计,其包括以下成分:
可选的,所述增稠悬浮组合物按质量百分比计,其包括以下成分:
卡波姆 0.01~0.2%;
皱波角叉菜粉 0.001~0.2%;
藻酸钠 0.02~0.2%。
可选的,按质量百分比计,其包括以下成分:
可选的,按质量百分比计,其包括以下成分:
可选的,一种双层精华水的制备方法包括以下步骤:
步骤一:按配方原料依次称好各组原料并记录;将甘油、丙二醇、海藻糖、卡波姆、皱波角叉菜粉、藻酸钠及水加入到配料锅中,得到A混合物;
步骤二:对A混合物进行均质、搅拌加热至85℃~90℃,搅拌分散直至原料混合均匀,继续保温30~50分钟,得到B溶液;
步骤三:对B溶液进行降温至42℃~45℃后,加入1,2-己二醇、丁二醇及对羟基苯乙酮并搅拌均匀,得到C溶液;
步骤四:对C溶液继续降温至40℃后,加入糖类同分异构体、柠檬酸、柠檬酸钠及辛酰羟肟酸并搅拌均匀,然后过滤出料,得到D溶液;
步骤五:将环五聚二甲基硅氧烷、葡萄籽油、霍霍巴籽油及香精加入到D溶液中,并常温下搅拌均匀,即可得到一种双层精华水。
本发明中的卡波姆在很低的用量下,就能产生增稠作用,能使液态物系具有特别的屈服值及流变性,只需很低的浓度就能使油滴达到悬浮;同时对皮肤有极高的亲和性,对皮肤能够起到呵护的作用,避免一切成分的刺激;并且它的活性很高,能够抵抗紫外线对皮肤的照射。
皱波角叉菜粉作为增稠剂使用,可以锁住水分,提高皮肤的吸收时间;还可以促进胶原蛋白的生成,激活细胞活性,针对皱纹有抚平的作用,调理粗糙角质,让皮肤富有弹性。
藻酸钠是从褐藻类的海带或马尾藻中提取碘和甘露醇之后的副产物,是一种天然多糖,具有稳定的保湿性;对肌肤有很大的治疗效果,让松弛的肌肤轻松恢复紧缩性,去除皱纹,改善干性和有型肌肤的分泌状态,促使毛孔收缩,还能防止油脂分泌过剩。
海藻糖壳体提高皮肤适应环境能力,防止油脂分解,在严重脱水时,可代替细胞中水分的作用;能有效清除自由基,使皮肤细胞DNA不易发生突变,有效保护皮肤受由放射线引起的损伤。
1,2-己二醇及丁二醇降低精华水被有害细菌感染的风险;同时对羟苯乙酮能有效降低肌肤自身氧化给皮肤造成的压力。
糖类同分异构体及辛酰羟肟酸作为皮肤调理剂,多角度提供肌肤进行生理活动的有益环境,增强肌肤自身更新的能力。
葡萄籽油能高效地清除自由基,且易于皮肤结缔组织吸收,可协助保护皮肤免受紫外线损害,滋养皮肤,减少皮肤病和皱纹,甚至消除疤痕。
霍霍巴籽油含皮肤重要天然维生素及含高滋养度的胶原蛋白质、矿物质,可按摩及保护皮肤,避免水分流失,滋养深层呵护肌肤,使皮肤光泽具有弹性,并缓和风吹日晒对肌肤的伤害;同时极易被皮肤吸收,清爽滋润、不油腻,能恢复皮肤pH平衡,去皱纹,有效改善油性皮肤,调理皮脂腺分泌机能,收缩毛孔,其形成的油膜可透过蒸发的水分,也能控制水分的损失。
本发明相对于现有技术具有如下的优点:油相能均匀稳定地悬浮在水相中,具有轻盈清爽的质地,长效的保湿效果,调节混合性肌肤水油不平衡的状态,细致毛孔,提高肌肤整体的透彻感、滋润感。
具体实施方式
下面结合实施例对本发明作进一步的描述,但本发明要求保护的范围并不局限于实施例表述的范围。
本发明实施例1~3的双层精华液的组分配方如下:
实施例1~3所述的双层精华液的制备方法包括以下步骤:
步骤一:按配方原料依次称好各组原料并记录;将甘油、丙二醇、海藻糖、卡波姆、皱波角叉菜粉、藻酸钠及水加入到配料锅中,得到A混合物;
步骤二:对A混合物进行均质、搅拌加热至85℃~90℃,搅拌分散直至原料混合均匀,继续保温30~50分钟,得到B溶液;其中均质转速为25~50Hz,搅拌转速为10~15rpm。
步骤三:对B溶液进行降温至42℃~45℃后,加入1,2-己二醇、丁二醇及对羟基苯乙酮并搅拌均匀,得到C溶液;其中搅拌转速为10~15rpm,搅拌时间为8~10分钟。
步骤四:对C溶液继续降温至40℃后,加入糖类同分异构体、柠檬酸、柠檬酸钠及辛酰羟肟酸并搅拌均匀,然后过滤出料,得到D溶液;
步骤五:将环五聚二甲基硅氧烷、葡萄籽油、霍霍巴籽油及香精加入D溶液中,并常温下搅拌均匀,即可得到一种双层精华水。
对比例
市场上销售的某品牌双层保湿精华水。
试验一外观试验
将实施例1~3制得的双层精华水及对比例的精华水摇匀后,各取5ml于不同的试管内静置5min,记录精华水的分层状况及浑浊状况,以0~10分表示,0分表示精华水不分层或澄清透明,10分表示精华水完全分层或完全浑浊,试验数据如表1所示:
表1不同精华水的外观状况数据表
从表1可以看出:得益于本发明的配方组合,实施例1~3的精华水无论是分层状况还是浑浊状况均明显优于对比例中的双层精华水。
试验二保湿试验
试验方法:选取年龄段20~40岁的女性志愿者100名,随机分为4组,每组25名;不同组别的志愿者分别在清洗干净的脸颊上涂抹实施例1~3及对比例中的精华水;在使用前、使用后2h、12h、24h及120h分别进行测试,其中超过24h的,每天早晚各一次。
使用皮肤水分测试仪测定涂抹部分的皮肤含水量,测量3次计算平均值作为测试值,计算使用前、使用后不同时间段的含水量变化率,计算公式为:皮肤含水量变化率=(使用后含水量-使用前含水量)/使用后含水量*100%。
表2不同精华水的皮肤含水量变化率
从表2可以看出:实施例1~3在使用2h后,皮肤含水量明显提升,随着时间的延长含水量呈递增趋势,说明本发明的精华水具有长效的保湿效果;相对于对比例中精华水,实施例1~3在使用120h后皮肤含水率均远远高于对比例。
试验三其它测试
试验方法:选取年龄段20~40岁的女性志愿者100名,随机分为4组,每组25名;不同组别的志愿者分别在清洗干净的脸颊上涂抹实施例1~3及对比例中的精华水;每天早晚各一次,连续使用30天,实验结果如下:
表3不同精华水的皮肤状态变化表
从表3可以看出:实施例1~3在使用30天后,皮肤弹性与皮肤光滑度得到约10%的提升、毛孔直径与有害细菌含量约降低了9%;而对比例中除了光滑度提升了5.6%,其它测试项目变化不明显;由此可见本发明的双层精华水具有细化毛孔、修复肌肤和消炎抗敏等功效。
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (5)
2.根据权利要求1所述的一种双层精华水,其特征在于,所述增稠悬浮组合物按质量百分比计,其包括以下成分:
卡波姆 0.01~0.2%;
皱波角叉菜粉 0.001~0.2%;
藻酸钠 0.02~0.2%。
5.根据权利要求1-4任一项所述的一种双层精华水的制备方法,其特征在于,所述制备方法包括以下步骤:
步骤一:按配方原料依次称好各组原料并记录;将甘油、丙二醇、海藻糖、卡波姆、皱波角叉菜粉、藻酸钠及水加入到配料锅中,得到A混合物;
步骤二:对A混合物进行均质、搅拌加热至85℃~90℃,搅拌分散直至原料混合均匀,继续保温30~50分钟,得到B溶液;
步骤三:对B溶液进行降温至42℃~45℃后,加入1,2-己二醇、丁二醇及对羟基苯乙酮并搅拌均匀,得到C溶液;
步骤四:对C溶液继续降温至40℃后,加入糖类同分异构体、柠檬酸、柠檬酸钠及辛酰羟肟酸并搅拌均匀,然后过滤出料,得到D溶液;
步骤五:将环五聚二甲基硅氧烷、葡萄籽油、霍霍巴籽油及香精加入到D溶液中,并常温下搅拌均匀,即可得到一种双层精华水。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111174469.3A CN113693973A (zh) | 2021-10-09 | 2021-10-09 | 一种双层精华水及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111174469.3A CN113693973A (zh) | 2021-10-09 | 2021-10-09 | 一种双层精华水及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113693973A true CN113693973A (zh) | 2021-11-26 |
Family
ID=78662607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111174469.3A Pending CN113693973A (zh) | 2021-10-09 | 2021-10-09 | 一种双层精华水及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113693973A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147528A (zh) * | 2015-07-23 | 2015-12-16 | 广州神采化妆品有限公司 | 一种水乳双层精华乳液及其制备方法 |
CN109431963A (zh) * | 2018-12-25 | 2019-03-08 | 广州蔻赛生物科技有限公司 | 一种透明油珠悬浮精华水及其制备方法 |
CN111671703A (zh) * | 2020-06-24 | 2020-09-18 | 陕西斯堪纳维亚生物科技有限公司 | 一种控油补水双向调节精华水 |
CN112716814A (zh) * | 2020-12-29 | 2021-04-30 | 彭氏(惠州)实业发展有限公司 | 一种双层摇摇精华及其制备方法 |
CN112999105A (zh) * | 2021-03-24 | 2021-06-22 | 广州市迪笙生物科技有限公司 | 一种高保湿的精华水及其制备方法 |
-
2021
- 2021-10-09 CN CN202111174469.3A patent/CN113693973A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147528A (zh) * | 2015-07-23 | 2015-12-16 | 广州神采化妆品有限公司 | 一种水乳双层精华乳液及其制备方法 |
CN109431963A (zh) * | 2018-12-25 | 2019-03-08 | 广州蔻赛生物科技有限公司 | 一种透明油珠悬浮精华水及其制备方法 |
CN111671703A (zh) * | 2020-06-24 | 2020-09-18 | 陕西斯堪纳维亚生物科技有限公司 | 一种控油补水双向调节精华水 |
CN112716814A (zh) * | 2020-12-29 | 2021-04-30 | 彭氏(惠州)实业发展有限公司 | 一种双层摇摇精华及其制备方法 |
CN112999105A (zh) * | 2021-03-24 | 2021-06-22 | 广州市迪笙生物科技有限公司 | 一种高保湿的精华水及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110051587A (zh) | 一种含多种玻尿酸的抗衰老组合物的制备方法和应用 | |
CN111067816A (zh) | 一种含活性多肽的保湿修复面膜及其制备方法 | |
CN109106664A (zh) | 具有保湿舒缓修护功效的组合物、面膜及其制备方法 | |
CN116003577B (zh) | 一种用于皮肤舒缓修复的重组胶原蛋白及其应用 | |
CN110693767B (zh) | 一种具有净肤效果的冰川矿物泥膜及其制备方法 | |
CN110946813B (zh) | 一种含燕窝的复合发酵提取物及其制备方法和应用 | |
CN113304075B (zh) | 一种冰川岩清洁控油泥膜及其制备方法 | |
CN108434086A (zh) | 含有南极洲丛梗藻提取物的组合物及其化妆品 | |
CN109998937B (zh) | 含有甘油葡糖苷(αGG)的系列化妆品及其制备方法 | |
CN112516051A (zh) | 一种铁皮石斛沁肌紧肤精华液及其制备方法 | |
CN111671708A (zh) | 一种平衡修复肌肤用益生菌复合物化妆品及其制备方法 | |
CN103893028A (zh) | 一种海藻类面膜 | |
CN112168766A (zh) | 一种抗炎舒缓芦荟胶及其制备方法 | |
CN109718180B (zh) | 一种芦荟果冻泥面膜及其制备方法 | |
CN108158886A (zh) | 一种保湿组合物及其应用 | |
CN108309875B (zh) | 滋润保湿面霜及其制备方法 | |
CN112999105A (zh) | 一种高保湿的精华水及其制备方法 | |
CN113693973A (zh) | 一种双层精华水及其制备方法 | |
CN112043659A (zh) | 一种抗皱修复精华面霜 | |
CN111759762A (zh) | 祛黑眼圈组合物、精华及其制备方法 | |
CN108815002B (zh) | 一种含有水溶性神经酰胺的护肤品和护发品 | |
CN109288723A (zh) | 一种含有纳米纤维素的化妆品组合物及其制备方法 | |
CN108619020B (zh) | 一种含有苦槛蓝提取物的面膜及其制备方法 | |
CN114432179A (zh) | 壳聚糖补水修护精华液化妆品配方及其制备方法 | |
CN111053721A (zh) | 一种丝滑焕彩眼霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211126 |
|
RJ01 | Rejection of invention patent application after publication |